Pharmaceuticals, Journal Year: 2025, Volume and Issue: 18(3), P. 357 - 357
Published: March 2, 2025
Background/Objectives: Traditional Chinese medicine (TCM) has a long history and is known for its anti-inflammatory, antiviral, immunoregulatory qualities. It been extensively studied during the COVID-19 pandemic. Therefore, to evaluate relationship between TCM treatment of COVID-19, we conducted meta-analysis. Methods: Our meta-analysis included 22 randomized clinical trials, which investigated analyzed endpoints: time recovery from fever, severity dyspnea or breathlessness according on different scales, coughing, including dry wet fatigue, changes in respiratory rate, length hospitalization, hospital discharging number intensive care unit (ICU) admissions, cases requiring any supplemental oxygenation, deaths among patients, conversion rate SARS-CoV-2 tests particular day, viral assay conversion. The relative risk (RR) with 95% confidence intervals (CIs) mean difference standardized CIs were calculated compare effect. A random effects model was used calculate effect sizes. Results: We indicated positive symptoms. influences hospitalization duration, ICU admission, mortality, patients. Moreover, positively affects test rates days (RR = 1.21; CI [1.10; 1.32]; p < 0.0001; I2 84%). Conclusions: may potentially support standard COVID-19. Nevertheless, necessity further trials greater participants wider range countries remains apparent.
Language: Английский